Russ Hawkinson - Dec 8, 2020 Form 4/A - Amendment Insider Report for Silverback Therapeutics, Inc. (SPRY)

Role
Sr. Vice President of Finance
Signature
/s/ Jeffrey C. Pepe, Attorney-in-Fact
Stock symbol
SPRY
Transactions as of
Dec 8, 2020
Transactions value $
$4,200
Form type
4/A - Amendment
Date filed
2/24/2022, 06:55 PM
Date Of Original Report
Dec 8, 2020
Next filing
Feb 2, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SPRY Common Stock Purchase $4.2K +200 $21.00 200 Dec 8, 2020 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were purchased in the Issuer's initial public offering.
F2 On December 8, 2020, the reporting person filed a Form 4 in which he inadvertently reported a purchase of 238 shares of the issuer's common stock. In fact, as reported in this amendment, the reporting person purchased 200 shares of the issuer's common stock.